Global Genomics Supply, Demand and Key Producers, 2023-2029

Report ID: GIR2301140016 | Category: Service & Software | Pages: 112 | Format: PDF | Published Date: February 13,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4480.00 Multi User-$6720.00

Report Description
View Table of Contents

Report Summary

The global Genomics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Genomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genomics total market, 2018-2029, (USD Million)
Global Genomics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Genomics total market, key domestic companies and share, (USD Million)
Global Genomics revenue by player and market share 2018-2023, (USD Million)
Global Genomics total market by Type, CAGR, 2018-2029, (USD Million)
Global Genomics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Genomics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 10X Genomics Inc., Abcam Plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Genomics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Genomics Market, Segmentation by Type
Nucleic Acids Extraction and QC
Gene Expression Services
Genotyping Services and Pharmacogenomics
Data Analysis and Interpretation
Others
Global Genomics Market, Segmentation by Application
Hospitals and Clinics
Pharmaceutical
Research Institutes
Agrochemical
Chemical
Others
Companies Profiled:
10X Genomics Inc.
Abcam Plc
Agilent Technologies Inc.
Becton Dickinson and Co.
BGI Genomics Co. Ltd.
Bio Rad Laboratories Inc.
Danaher Corp.
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
IQVIA
Beckman Coulter
Key Questions Answered
1. How big is the global Genomics market?
2. What is the demand of the global Genomics market?
3. What is the year over year growth of the global Genomics market?
4. What is the total value of the global Genomics market?
5. Who are the major players in the global Genomics market?
6. What are the growth factors driving the market demand?

1 Supply Summary_x000D_
    1.1 Genomics Introduction_x000D_
    1.2 World Genomics Market Size & Forecast (2018 & 2022 & 2029)_x000D_
    1.3 World Genomics Total Market by Region (by Headquarter Location)_x000D_
        1.3.1 World Genomics Market Size by Region (2018-2029), (by Headquarter Location)_x000D_
        1.3.2 United States Genomics Market Size (2018-2029)_x000D_
        1.3.3 China Genomics Market Size (2018-2029)_x000D_
        1.3.4 Europe Genomics Market Size (2018-2029)_x000D_
        1.3.5 Japan Genomics Market Size (2018-2029)_x000D_
        1.3.6 South Korea Genomics Market Size (2018-2029)_x000D_
        1.3.7 ASEAN Genomics Market Size (2018-2029)_x000D_
        1.3.8 India Genomics Market Size (2018-2029)_x000D_
    1.4 Market Drivers, Restraints and Trends_x000D_
        1.4.1 Genomics Market Drivers_x000D_
        1.4.2 Factors Affecting Demand_x000D_
        1.4.3 Genomics Major Market Trends_x000D_
    1.5 Influence of COVID-19 and Russia-Ukraine War_x000D_
        1.5.1 Influence of COVID-19_x000D_
        1.5.2 Influence of Russia-Ukraine War_x000D_
2 Demand Summary_x000D_
    2.1 World Genomics Consumption Value (2018-2029)_x000D_
    2.2 World Genomics Consumption Value by Region_x000D_
        2.2.1 World Genomics Consumption Value by Region (2018-2023)_x000D_
        2.2.2 World Genomics Consumption Value Forecast by Region (2024-2029)_x000D_
    2.3 United States Genomics Consumption Value (2018-2029)_x000D_
    2.4 China Genomics Consumption Value (2018-2029)_x000D_
    2.5 Europe Genomics Consumption Value (2018-2029)_x000D_
    2.6 Japan Genomics Consumption Value (2018-2029)_x000D_
    2.7 South Korea Genomics Consumption Value (2018-2029)_x000D_
    2.8 ASEAN Genomics Consumption Value (2018-2029)_x000D_
    2.9 India Genomics Consumption Value (2018-2029)_x000D_
3 World Genomics Companies Competitive Analysis_x000D_
    3.1 World Genomics Revenue by Player (2018-2023)_x000D_
    3.2 Industry Rank and Concentration Rate (CR)_x000D_
        3.2.1 Global Genomics Industry Rank of Major Players_x000D_
        3.2.2 Global Concentration Ratios (CR4) for Genomics in 2022_x000D_
        3.2.3 Global Concentration Ratios (CR8) for Genomics in 2022_x000D_
    3.3 Genomics Company Evaluation Quadrant_x000D_
    3.4 Genomics Market: Overall Company Footprint Analysis_x000D_
        3.4.1 Genomics Market: Region Footprint_x000D_
        3.4.2 Genomics Market: Company Product Type Footprint_x000D_
        3.4.3 Genomics Market: Company Product Application Footprint_x000D_
    3.5 Competitive Environment_x000D_
        3.5.1 Historical Structure of the Industry_x000D_
        3.5.2 Barriers of Market Entry_x000D_
        3.5.3 Factors of Competition_x000D_
    3.6 Mergers, Acquisitions Activity_x000D_
4 United States VS China VS Rest of the World (by Headquarter Location)_x000D_
    4.1 United States VS China: Genomics Revenue Comparison (by Headquarter Location)_x000D_
        4.1.1 United States VS China: Genomics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)_x000D_
        4.1.2 United States VS China: Genomics Revenue Market Share Comparison (2018 & 2022 & 2029)_x000D_
    4.2 United States Based Companies VS China Based Companies: Genomics Consumption Value Comparison_x000D_
        4.2.1 United States VS China: Genomics Consumption Value Comparison (2018 & 2022 & 2029)_x000D_
        4.2.2 United States VS China: Genomics Consumption Value Market Share Comparison (2018 & 2022 & 2029)_x000D_
    4.3 United States Based Genomics Companies and Market Share, 2018-2023_x000D_
        4.3.1 United States Based Genomics Companies, Headquarters (States, Country)_x000D_
        4.3.2 United States Based Companies Genomics Revenue, (2018-2023)_x000D_
    4.4 China Based Companies Genomics Revenue and Market Share, 2018-2023_x000D_
        4.4.1 China Based Genomics Companies, Company Headquarters (Province, Country)_x000D_
        4.4.2 China Based Companies Genomics Revenue, (2018-2023)_x000D_
    4.5 Rest of World Based Genomics Companies and Market Share, 2018-2023_x000D_
        4.5.1 Rest of World Based Genomics Companies, Headquarters (States, Country)_x000D_
        4.5.2 Rest of World Based Companies Genomics Revenue, (2018-2023)_x000D_
5 Market Analysis by Type_x000D_
    5.1 World Genomics Market Size Overview by Type: 2018 VS 2022 VS 2029_x000D_
    5.2 Segment Introduction by Type_x000D_
        5.2.1 Nucleic Acids Extraction and QC_x000D_
        5.2.2 Gene Expression Services_x000D_
        5.2.3 Genotyping Services and Pharmacogenomics_x000D_
        5.2.4 Data Analysis and Interpretation_x000D_
        5.2.5 Others_x000D_
    5.3 Market Segment by Type_x000D_
        5.3.1 World Genomics Market Size by Type (2018-2023)_x000D_
        5.3.2 World Genomics Market Size by Type (2024-2029)_x000D_
        5.3.3 World Genomics Market Size Market Share by Type (2018-2029)_x000D_
6 Market Analysis by Application_x000D_
    6.1 World Genomics Market Size Overview by Application: 2018 VS 2022 VS 2029_x000D_
    6.2 Segment Introduction by Application_x000D_
        6.2.1 Hospitals and Clinics_x000D_
        6.2.2 Pharmaceutical_x000D_
        6.2.3 Research Institutes_x000D_
        6.2.4 Agrochemical_x000D_
        6.2.5 Agrochemical_x000D_
        6.2.6 Others_x000D_
    6.3 Market Segment by Application_x000D_
        6.3.1 World Genomics Market Size by Application (2018-2023)_x000D_
        6.3.2 World Genomics Market Size by Application (2024-2029)_x000D_
        6.3.3 World Genomics Market Size by Application (2018-2029)_x000D_
7 Company Profiles_x000D_
    7.1 10X Genomics Inc._x000D_
        7.1.1 10X Genomics Inc. Details_x000D_
        7.1.2 10X Genomics Inc. Major Business_x000D_
        7.1.3 10X Genomics Inc. Genomics Product and Services_x000D_
        7.1.4 10X Genomics Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.1.5 10X Genomics Inc. Recent Developments/Updates_x000D_
        7.1.6 10X Genomics Inc. Competitive Strengths & Weaknesses_x000D_
    7.2 Abcam Plc_x000D_
        7.2.1 Abcam Plc Details_x000D_
        7.2.2 Abcam Plc Major Business_x000D_
        7.2.3 Abcam Plc Genomics Product and Services_x000D_
        7.2.4 Abcam Plc Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.2.5 Abcam Plc Recent Developments/Updates_x000D_
        7.2.6 Abcam Plc Competitive Strengths & Weaknesses_x000D_
    7.3 Agilent Technologies Inc._x000D_
        7.3.1 Agilent Technologies Inc. Details_x000D_
        7.3.2 Agilent Technologies Inc. Major Business_x000D_
        7.3.3 Agilent Technologies Inc. Genomics Product and Services_x000D_
        7.3.4 Agilent Technologies Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.3.5 Agilent Technologies Inc. Recent Developments/Updates_x000D_
        7.3.6 Agilent Technologies Inc. Competitive Strengths & Weaknesses_x000D_
    7.4 Becton Dickinson and Co._x000D_
        7.4.1 Becton Dickinson and Co. Details_x000D_
        7.4.2 Becton Dickinson and Co. Major Business_x000D_
        7.4.3 Becton Dickinson and Co. Genomics Product and Services_x000D_
        7.4.4 Becton Dickinson and Co. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.4.5 Becton Dickinson and Co. Recent Developments/Updates_x000D_
        7.4.6 Becton Dickinson and Co. Competitive Strengths & Weaknesses_x000D_
    7.5 BGI Genomics Co. Ltd._x000D_
        7.5.1 BGI Genomics Co. Ltd. Details_x000D_
        7.5.2 BGI Genomics Co. Ltd. Major Business_x000D_
        7.5.3 BGI Genomics Co. Ltd. Genomics Product and Services_x000D_
        7.5.4 BGI Genomics Co. Ltd. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.5.5 BGI Genomics Co. Ltd. Recent Developments/Updates_x000D_
        7.5.6 BGI Genomics Co. Ltd. Competitive Strengths & Weaknesses_x000D_
    7.6 Bio Rad Laboratories Inc._x000D_
        7.6.1 Bio Rad Laboratories Inc. Details_x000D_
        7.6.2 Bio Rad Laboratories Inc. Major Business_x000D_
        7.6.3 Bio Rad Laboratories Inc. Genomics Product and Services_x000D_
        7.6.4 Bio Rad Laboratories Inc. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.6.5 Bio Rad Laboratories Inc. Recent Developments/Updates_x000D_
        7.6.6 Bio Rad Laboratories Inc. Competitive Strengths & Weaknesses_x000D_
    7.7 Danaher Corp._x000D_
        7.7.1 Danaher Corp. Details_x000D_
        7.7.2 Danaher Corp. Major Business_x000D_
        7.7.3 Danaher Corp. Genomics Product and Services_x000D_
        7.7.4 Danaher Corp. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.7.5 Danaher Corp. Recent Developments/Updates_x000D_
        7.7.6 Danaher Corp. Competitive Strengths & Weaknesses_x000D_
    7.8 Eppendorf AG_x000D_
        7.8.1 Eppendorf AG Details_x000D_
        7.8.2 Eppendorf AG Major Business_x000D_
        7.8.3 Eppendorf AG Genomics Product and Services_x000D_
        7.8.4 Eppendorf AG Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.8.5 Eppendorf AG Recent Developments/Updates_x000D_
        7.8.6 Eppendorf AG Competitive Strengths & Weaknesses_x000D_
    7.9 Eurofins Scientific SE_x000D_
        7.9.1 Eurofins Scientific SE Details_x000D_
        7.9.2 Eurofins Scientific SE Major Business_x000D_
        7.9.3 Eurofins Scientific SE Genomics Product and Services_x000D_
        7.9.4 Eurofins Scientific SE Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.9.5 Eurofins Scientific SE Recent Developments/Updates_x000D_
        7.9.6 Eurofins Scientific SE Competitive Strengths & Weaknesses_x000D_
    7.10 F. Hoffmann-La Roche Ltd._x000D_
        7.10.1 F. Hoffmann-La Roche Ltd. Details_x000D_
        7.10.2 F. Hoffmann-La Roche Ltd. Major Business_x000D_
        7.10.3 F. Hoffmann-La Roche Ltd. Genomics Product and Services_x000D_
        7.10.4 F. Hoffmann-La Roche Ltd. Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates_x000D_
        7.10.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses_x000D_
    7.11 IQVIA_x000D_
        7.11.1 IQVIA Details_x000D_
        7.11.2 IQVIA Major Business_x000D_
        7.11.3 IQVIA Genomics Product and Services_x000D_
        7.11.4 IQVIA Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.11.5 IQVIA Recent Developments/Updates_x000D_
        7.11.6 IQVIA Competitive Strengths & Weaknesses_x000D_
    7.12 Beckman Coulter_x000D_
        7.12.1 Beckman Coulter Details_x000D_
        7.12.2 Beckman Coulter Major Business_x000D_
        7.12.3 Beckman Coulter Genomics Product and Services_x000D_
        7.12.4 Beckman Coulter Genomics Revenue, Gross Margin and Market Share (2018-2023)_x000D_
        7.12.5 Beckman Coulter Recent Developments/Updates_x000D_
        7.12.6 Beckman Coulter Competitive Strengths & Weaknesses_x000D_
8 Industry Chain Analysis_x000D_
    8.1 Genomics Industry Chain_x000D_
    8.2 Genomics Upstream Analysis_x000D_
    8.3 Genomics Midstream Analysis_x000D_
    8.4 Genomics Downstream Analysis_x000D_
9 Research Findings and Conclusion_x000D_
10 Appendix_x000D_
    10.1 Methodology_x000D_
    10.2 Research Process and Data Source_x000D_
    10.3 Disclaimer_x000D_

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Genomics Supply, Demand and Key Producers, 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?